Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.

Stephen Falk, Simon Gollins, John Staffurth, R Ray, Andrew Bridgewater, J Ian Geh, Jane Blazeby, Georgina Griffiths

Research output: Contribution to journalArticle (Academic Journal)peer-review

33 Citations (Scopus)
267 Downloads (Pure)

Search results